Article: STI Completes Cervical Cancer Trials in Lithuania Using the World's First Cervical Cancer Imager.

Business Editors/Health & Medical Writers

NOTE TO MEDIA: Photo/Logo is available in a

Smart News Release(TM) on Business Wire's Home Page at

www.businesswire.com and at www.newstream.com

HONOLULU--(BUSINESS WIRE)--Feb. 6, 2002

Science & Technology International(R), STI, announced today it has completed cervical cancer trials in Vilnius, Lithuania. STI is using what is believed to be the world's first cervical cancer detection imaging instrument that is a non-invasive, non-contact and pain-free approach to diagnoses. STI designs, develops and manufactures the HyperSpectral Diagnostic Imaging (HSDI)(TM) system. To date, STI has ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!